Blackstone reportedly to sell Alinamin subsidiary for $2.2B

Blackstone Inc. will sell Alinamin Pharmaceutical Co., Ltd., its subsidiary focused on pharmaceutical products and based in Japan, to the private equity firm MBK Partners (MBKP) for $2.2 billion, Nikk…